Icon

BETHKIS (nda201820)- (300MG/4ML)

TOBRAMYCIN CHIESI
300MG/4ML
Yes Yes
2023-Mar-17 Expired
None None
None No
BETHKIS is an inhaled aminoglycoside antibacterial indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa.
2 0 2
Total Other Developers 3
Drugs with Suitability No
300MG/4ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** *** ****** ********** ******* *********** ***** **** *****, ********** **** ********** ******, ******* *****, *******, ******** *** ***, ****** ******* (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.